Apigenin

With peptides

Apigenin pairs naturally with the Russian-origin sleep + longevity peptide cluster — and is one of the few supplements that spans both Russian-sleep and NAD+/longevity peptide clusters via its dual mechanism. DSIP (delta sleep-inducing peptide) operates directly on slow-wave sleep architecture — peptide-level intervention on sleep depth. Selank (a tuftsin analog) provides anxiolytic effects via GABA-A receptor sensitivity modulation — same broad target as apigenin but at a different mechanism layer. Epitalon adds the pineal-axis longevity arm — telomere maintenance and circadian regulation, complementary to apigenin's CD38/NAD+ longevity arm. Add NAD+ peptide for users wanting direct NAD+ delivery alongside apigenin's consumption-side preservation. Mechanistically complementary across the cluster, no known negative interactions.

With supplements

1. NMN or NAD+ precursors — apigenin's CD38 inhibition preserves the NAD+ that NMN/NR provide. Combining the two addresses both sides of the NAD+ balance equation (more substrate in, less destruction).
2. Magnesium glycinate — magnesium is a GABA-A positive allosteric modulator. Pairs cleanly with apigenin's benzodiazepine-site partial agonism at the same receptor.
3. Glycine — body-temperature regulation for sleep onset + inhibitory neurotransmission. Different sleep mechanism; mechanistically complementary.
4. L-theanine — alpha-wave induction + GABAergic enhancement via different mechanism. Compatible.
5. Melatonin — circadian signaling. Different mechanism (MT1/MT2 receptor) from apigenin's GABA-A target; fully compatible.
6. Tart cherry — natural melatonin + tryptophan + anthocyanin botanical matrix. Compatible botanical sleep-stack pairing.
7. Quercetin — another flavonoid with anti-inflammatory and CD38-adjacent effects. Common longevity-stack co-occupant.

With lifestyle

1. Pre-bed timing with dietary fat. 30–60 minutes before target bedtime, taken with a small amount of fat (few nuts, olive oil) for absorption.
2. Avoid combining with alcohol or sedatives. Same GABA-A receptor system as benzodiazepines and alcohol; additive CNS depression risk. Separate dosing.
3. Chamomile tea as adjunct. Pleasant wind-down ritual that adds a small amount of apigenin alongside other chamomile flavonoids; complements supplemental dosing.
4. Track sleep impact. Effects on sleep onset and quality are modest — track subjectively or with sleep-tracking tools to assess individual response over 2–4 weeks.
5. Avoid during pregnancy. Concentrated supplemental doses; uterine activity concerns at high doses. Culinary chamomile tea generally considered safer in pregnancy but defer to OB.

Common (mostly transient)

1. Mild drowsiness — intentional for sleep applications; undesirable if dosed during waking hours.
2. Mild GI discomfort — occasional, generally at higher doses or empty stomach.
3. Vivid dreams — occasionally reported; likely tied to GABAergic effects on sleep architecture.
4. No documented serious adverse events at standard supplemental doses across the human research base.

Less common (watch-list)

1. Asteraceae (daisy family) allergy reactions. Users with allergies to ragweed, chrysanthemums, daisies, marigolds may react to chamomile-derived apigenin. Switch to synthetic source if available, or avoid.
2. Pregnancy uterine activity concerns. Concentrated apigenin theoretically may trigger uterine activity at high doses. Avoid supplemental apigenin during pregnancy; culinary chamomile tea generally considered safer.
3. Hypotension at very high doses — apigenin has modest blood-pressure-lowering effects in some animal studies.

Drug and supplement interactions

1. CYP2C9 and CYP3A4 substrates. Apigenin inhibits these cytochrome P450 enzymes; may affect metabolism of warfarin, statins, certain antidepressants (SSRIs metabolized by CYP3A4), and some calcium channel blockers. Clinically meaningful for narrow-therapeutic-index drugs. Coordinate with prescribing clinician.
2. Anticoagulants (warfarin, apixaban, rivaroxaban). Mild antiplatelet effect + CYP2C9 inhibition affecting warfarin metabolism. Monitor INR for warfarin users; coordinate with prescribing clinician.
3. Alcohol and benzodiazepines. Same GABA-A receptor system; additive CNS depression possible. Avoid combining with alcohol or benzodiazepines without medical guidance.
4. Z-drugs (Ambien, Lunesta). Same GABA-A target; additive sedation. Avoid combining.
5. Other GABAergic supplements — generally compatible (see Stacks section) but watch total inhibitory tone if stacking aggressively.
6. Pregnancy — avoid supplemental apigenin. Culinary chamomile generally safer.

How much apigenin should I take?

50 mg taken 30–60 minutes before bed is the most common protocol — popularized in part by Andrew Huberman's recommendations. This dose is extrapolated from animal data and chamomile extract studies rather than direct human RCTs of pure apigenin (the evidence base is thinner than the popularity suggests). Start at 50 mg and adjust based on individual response. Higher doses (100 mg) are sometimes used but lack additional evidence; lower doses (25 mg) may work for sensitive users. Take with a small amount of dietary fat for better absorption — apigenin is poorly water-soluble.

How does apigenin compare to chamomile tea?

Massive dose difference. A typical cup of chamomile tea provides ~1–5 mg apigenin; a 50 mg supplement provides 10–50× that amount in concentrated form. Chamomile extract products (standardized to specific apigenin content) sit between the two. The tea is pleasant as a wind-down ritual and provides apigenin alongside other chamomile flavonoids and aromatic compounds — meaningful for the overall sensory and habit-formation arm of sleep hygiene. The supplement provides the concentrated dose-dependent effect studied in animal models and extrapolated to human use. Use both if you want — the tea won't blunt the supplement.

Will apigenin cause dependence or tolerance like Xanax?

Current evidence suggests no. Apigenin is a partial agonist at the benzodiazepine binding site on GABA-A receptors — meaning it has a ceiling on receptor activation that prevents the deep receptor downregulation and chronic adaptation responsible for benzodiazepine dependence. Long-term human dependency studies on standalone apigenin are limited, but no concerning signals have emerged so far. The partial-agonist pharmacology is structurally distinct from full agonists like benzodiazepines and theoretically protects against dependence. Reasonable to use chronically without the withdrawal concerns of prescription anxiolytics.

Is the CD38/NAD+ longevity story for real?

The mechanism (CD38 inhibition preserving NAD+) is well-established in cell and animal studies. Apigenin inhibits CD38 — the enzyme that consumes NAD+ — meaning it acts on a different layer than NAD+ precursor supplements (NMN, NR, oral NAD+). The honest framing: combining a precursor (input side) with apigenin (consumption side) is mechanistically coherent. But whether oral apigenin at typical doses produces meaningful NAD+ elevation in humans, and whether this translates to longevity outcomes, remains unproven in humans. The mechanism is real; the clinical translation is mechanistically reasonable but not directly RCT-validated. Treat apigenin as a sleep aid with a possible longevity bonus, not a longevity intervention with sleep benefits.

Can I stack apigenin with DSIP or other sleep peptides?

Yes — and the stack is mechanistically natural and represents one of the strongest cluster-cohesive combinations in the Russian sleep + longevity territory. DSIP (delta sleep-inducing peptide) operates directly on slow-wave sleep architecture — peptide-level intervention on sleep depth. Selank (a tuftsin analog) provides anxiolytic effects via GABA-A receptor sensitivity modulation — same broad GABA-A target as apigenin but at a different mechanism layer (Selank modulates receptor sensitivity; apigenin is partial agonist at the benzodiazepine binding site). Epitalon adds the pineal-axis longevity arm — telomere maintenance and circadian regulation. The four-component stack (DSIP + Selank + Epitalon + apigenin) covers sleep architecture, anxiolytic GABA-A modulation, pineal-axis longevity, and benzodiazepine-site partial agonism + CD38/NAD+ preservation from four distinct mechanism layers. Mechanistically complementary, no known negative interactions.

Apigenin combined with NMN or NAD+ — does that pairing make sense?

Yes, and the mechanism layering is biochemically coherent. NMN and NAD+ precursors operate on the input side — feeding the salvage pathway to raise NAD+ levels. Apigenin operates on the consumption side — inhibiting CD38, the major NAD+-consuming enzyme that increases activity with aging and inflammation. Combining the two addresses both ends of the NAD+ balance equation: more substrate in (NMN/NR), less destruction (apigenin via CD38 inhibition). This is mechanistically natural for users building comprehensive NAD+ longevity protocols. The combination isn't rigorously RCT-validated as a combination, but the pharmacological rationale is mature.

What about apigenin during pregnancy?

Avoid concentrated apigenin supplements during pregnancy. Chamomile (and by extension apigenin) has historically been associated with uterine activity concerns at high doses, with theoretical risk of triggering contractions. Culinary chamomile tea (1–2 cups daily) is generally considered safe during pregnancy in most clinical practice, but concentrated 50 mg supplements deliver far higher apigenin per dose than tea provides. The evidence base for supplemental apigenin in pregnancy is essentially absent; the conservative recommendation is to avoid until breastfeeding ends or coordinate with OB if there's a clinical indication.

Does apigenin actually help with anxiety, or just sleep?

Both, with related mechanisms — but anxiety evidence comes mostly from chamomile extract studies rather than standalone apigenin. Chamomile extract has shown anxiolytic effects in RCTs in adults with generalized anxiety disorder; apigenin is the principal active flavonoid in chamomile, so the effect likely operates through apigenin's GABA-A partial agonism. Effect sizes are modest — not benzodiazepine-class — but real. Standalone apigenin extracts at 50 mg may produce similar anxiolytic effects via the same mechanism, though direct standalone-apigenin anxiety trials are limited. For mild-to-moderate anxiety: reasonable adjunct. For severe clinical anxiety: not a substitute for established treatment.